Literature DB >> 6302797

Experimental study in rabbits of the antishock effect of anisodamine (654-2), and its mechanism of action.

J Y Su, L Wu, C Tang.   

Abstract

The antishock effect of anisodamine (654-2) was observed in different kinds of experimental shock in groups of rabbits--due to late hemorrhage, superior mesenteric artery occlusion, and septic shock from peritonitis. The drug 654-2 significantly alleviated the progress of shock and increased the survival rate of the animals. The therapeutic effect of 654-2 was much better than that of other vasoactive drugs commonly used, such as norepinephrine, phenoxybenzamine, dopamine, and aramine. The antishock mechanism of 654-2 is probably partly due to its protective action on intestinal shock in preventing its effects becoming irreversible. The antishock action of 654-2 both by basic research workers and clinicians merits further study.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6302797     DOI: 10.1016/0300-9572(83)90005-9

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  4 in total

1.  Studies on cellular mechanism of the antishock action of anisodamine in rats--effect of anisodamine on the stability of liver lysosomes and comparison of its membrane-stabilizing action with that of dexamethasone.

Authors:  Y Zhu; J Y Su
Journal:  J Tongji Med Univ       Date:  1986

2.  [Dopaminergic effect of anisodamine on the microcirculation of the hydronephrotic kidney of rats].

Authors:  A P Zou; N Parekh; M Steinhausen
Journal:  J Tongji Med Univ       Date:  1991

3.  Specific inhibitory action of anisodamine against a staphylococcal superantigenic toxin, toxic shock syndrome toxin 1 (TSST-1), leading to down-regulation of cytokine production and blocking of TSST-1 toxicity in mice.

Authors:  Saori Nakagawa; Koji Kushiya; Ikue Taneike; Ken'ichi Imanishi; Takehiko Uchiyama; Tatsuo Yamamoto
Journal:  Clin Diagn Lab Immunol       Date:  2005-03

4.  Beneficial effects of anisodamine in shock involved cholinergic anti-inflammatory pathway.

Authors:  Ting Zhao; Dong-Jie Li; Chong Liu; Ding-Feng Su; Fu-Ming Shen
Journal:  Front Pharmacol       Date:  2011-05-02       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.